CPT 88302 Reimbursement Benchmarks & Policy | OpenPayer

Summary & Overview

CPT 88302: Surgical Pathology, Level II Tissue Examination

CPT code 88302 represents Level II surgical pathology, encompassing both gross and microscopic examination of tissue specimens. This procedure is a cornerstone in diagnostic medicine, enabling pathologists to identify and characterize disease processes through detailed tissue analysis. The code is widely recognized and reimbursed by major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare, underscoring its clinical and financial significance across the healthcare landscape.

This publication provides a comprehensive overview of CPT code 88302, including payer coverage, clinical context, and its role within the broader spectrum of surgical pathology codes. Readers will gain insights into typical laboratory settings where this service is performed, common billing practices, and relevant policy updates. The analysis also highlights associated taxonomies and ICD-10 diagnoses frequently linked to this code, offering a clear understanding of its application in patient care. Additionally, comparisons to related surgical pathology codes are presented to contextualize the level of complexity and scope of services provided under 88302. This resource is designed to inform healthcare professionals, billing specialists, and policy stakeholders about current benchmarks and regulatory considerations for surgical pathology services.

AetnaBlue Cross Blue ShieldCigna HealthMedicareUnitedHealthcareCPT 88302surgical pathologypathologylaboratory servicesgross and microscopic examinationmedical billingclinical contextpolicy updatesICD-10 diagnosesanatomic pathology

CPT Code Overview

CPT code 88302 is used for Level II surgical pathology services, specifically for the gross and microscopic examination of tissue specimens. This code is classified under the Pathology service type and is typically performed in a laboratory setting, designated as Place of Service 81. The procedure involves the evaluation of tissue samples to assist in the diagnosis and management of various medical conditions, providing essential information for clinical decision-making.

Clinical & Coding Specifications

Clinical Context

A patient presents with a skin lesion, mass, or swelling that requires further evaluation to determine its nature. The clinician performs a biopsy or excision of the tissue and submits the specimen to the laboratory. In the laboratory (Place of Service 81), a pathologist conducts a Level II surgical pathology examination, which includes both gross and microscopic analysis of the specimen. This process helps to identify whether the lesion is benign, malignant, or of uncertain behavior, guiding further clinical management.

Coding Specifications

Modifiers:
- Modifier 26: Used when reporting only the professional component of the pathology service (interpretation by the pathologist).
- Modifier TC: Used when reporting only the technical component (preparation and processing of the specimen in the laboratory).
Provider Taxonomies:

Taxonomy Code Specialty Name

National Reimbursement Benchmarks

Nationally, the mean rate for CPT code 88302 is highest with Blue Cross Blue Shield at $28.10, while Medicare's mean rate is $22.53. The average commercial mean rate, represented by BUCA, is $24.73, which is moderately higher than Medicare.

Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Blue Cross Blue Shield shows the widest spread at $17.70, indicating greater variability in rates. Cigna also has a wide dispersion at $20.50. In contrast, Aetna and UnitedHealth Group have tighter ranges, with dispersions of $11.67 and $13.00, respectively. Medicare's range is $25.00, reflecting significant variability.

The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.

State Benchmarks

State: Alaska1 / 51

Alaska Benchmarks

Alaska exhibits a wide rate spread for CPT code 88302, with Blue Cross Blue Shield showing a difference of $30.00 between the 75th and 25th percentiles, and Medicare displaying an even larger spread of $23.00. Aetna's rates are tightly clustered, with all percentiles at $84.33, indicating little variation. Compared to national averages, Alaska's commercial payers, especially Aetna and Blue Cross Blue Shield, reimburse at substantially higher rates, often more than double or triple their national mean values. Medicare's mean rate in Alaska is slightly below the national average, but its percentile spread is similar.

The table and chart below present the full breakdown of mean and percentile reimbursement rates for each payer in Alaska, highlighting the significant differences across payers and the elevated commercial rates relative to national benchmarks.

Key Insights for Alaska

Aetna is the highest paying payer for CPT 88302 in Alaska, with a mean rate of $80.62.
Medicare is the lowest paying payer, with a mean rate of $21.61, closely followed by Cigna Health at $23.31.
All commercial payers in Alaska reimburse at rates significantly above their respective national averages, with Aetna's mean rate more than triple the national mean.

CPT 88307: Surgical Pathology, Level V Tissue Examination

CPT-88366-IN-SITU-HYBRIDIZATION-MULTIPLEX-SINGLE-PROBE-INTERPRETATION

CPT 88366: In Situ Hybridization Multiplex Probe Stain with Interpretation

CPT-88333-INTRAOPERATIVE-PATHOLOGY-CONSULTATION-RAPID-CYTOLOGIC-EVALUATION

CPT 88333: Intraoperative Pathology Consultation, Rapid Cytologic Evaluation

CPT-88364-IN-SITU-HYBRIDIZATION-SINGLE-PROBE-ADD-ON-PATHOLOGY

CPT 88364: In Situ Hybridization Single-Probe Stain and Interpretation

CPT-88399-UNLISTED-SURGICAL-PATHOLOGY-PROCEDURE

CPT 88399: Unlisted Surgical Pathology Procedure

88300-THE-PHYSICIAN-TYPICALLY-A-PATHOLOGIST-PERFORMS-A-LEVEL-I

CPT 88300: Surgical Pathology, Level I Specimen Examination

CPT-88381-MANUAL-MICRODISSECTION-TISSUE-ISOLATION

CPT 88381: Manual Microdissection of Biopsy or Preserved Tissue

CPT-88358-MORPHOMETRIC-TUMOR-ANALYSIS-DNA-PLOIDY

CPT 88358: Morphometric Tumor Analysis for DNA Ploidy

CPT-88371-WESTERN-BLOT-PROTEIN-ANALYSIS-TISSUE

CPT 88371: Western Blot Protein Analysis of Tissue

88305-LEVEL-IV-SURGICAL-PATHOLOGY-GROSS-AND-MICROSCOPIC

CPT 88305: Surgical Pathology, Level IV Tissue Examination

Showing 1–10 of 47

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

OpenPayer

Summary & Overview

CPT 88302: Surgical Pathology, Level II Tissue Examination

CPT Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

National Reimbursement Benchmarks

State Benchmarks

Alaska Benchmarks

Key Insights for Alaska

Related Codes

Related Diagnoses

Related CPT Codes

National Reimbursement Benchmarks

State Benchmarks

Alaska Benchmarks

Key Insights for Alaska

Related Codes